Coloplast Management
Management criteria checks 4/4
Coloplast's CEO is Kristian Villumsen, appointed in Dec 2018, has a tenure of 5.92 years. total yearly compensation is DKK22.00M, comprised of 55.9% salary and 44.1% bonuses, including company stock and options. directly owns 0.045% of the company’s shares, worth DKK90.15M. The average tenure of the management team and the board of directors is 5.9 years and 6.8 years respectively.
Key information
Kristian Villumsen
Chief executive officer
DKK 22.0m
Total compensation
| CEO salary percentage | 55.9% |
| CEO tenure | 5.9yrs |
| CEO ownership | 0.04% |
| Management average tenure | 5.9yrs |
| Board average tenure | 6.8yrs |
Recent management updates
Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being
Nov 25
Recent updates
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's
Nov 13Earnings Update: Coloplast A/S (CPH:COLO B) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts
Nov 08Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly
Oct 18Coloplast A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 23Are Investors Undervaluing Coloplast A/S (CPH:COLO B) By 38%?
Aug 22Subdued Growth No Barrier To Coloplast A/S' (CPH:COLO B) Price
Jul 17These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Jun 29Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations
May 21Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00
May 10Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report
May 09A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)
Apr 26There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price
Apr 08Is Coloplast (CPH:COLO B) A Risky Investment?
Mar 21Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)
Jan 09Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings
Dec 22These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Dec 04Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues
Nov 16A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)
Sep 30Is Coloplast (CPH:COLO B) A Risky Investment?
Jun 28Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price
Jun 10Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly
Mar 22Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price
Mar 01These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Dec 14Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's
Nov 26Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being
Nov 25Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 11With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case
Oct 25Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)
Aug 26These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Jul 27Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching
Jul 12Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?
May 23Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00
May 08CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | DKK 22m | DKK 12m | DKK 5b |
| Jun 30 2024 | n/a | n/a | DKK 5b |
| Mar 31 2024 | n/a | n/a | DKK 5b |
| Dec 31 2023 | n/a | n/a | DKK 5b |
| Sep 30 2023 | DKK 23m | DKK 12m | DKK 5b |
| Jun 30 2023 | n/a | n/a | DKK 5b |
| Mar 31 2023 | n/a | n/a | DKK 5b |
| Dec 31 2022 | n/a | n/a | DKK 5b |
| Sep 30 2022 | DKK 21m | DKK 12m | DKK 5b |
| Jun 30 2022 | n/a | n/a | DKK 5b |
| Mar 31 2022 | n/a | n/a | DKK 5b |
| Dec 31 2021 | n/a | n/a | DKK 5b |
| Sep 30 2021 | DKK 22m | DKK 11m | DKK 5b |
| Jun 30 2021 | n/a | n/a | DKK 5b |
| Mar 31 2021 | n/a | n/a | DKK 4b |
| Dec 31 2020 | n/a | n/a | DKK 4b |
| Sep 30 2020 | DKK 20m | DKK 11m | DKK 4b |
| Jun 30 2020 | n/a | n/a | DKK 4b |
| Mar 31 2020 | n/a | n/a | DKK 4b |
| Dec 31 2019 | n/a | n/a | DKK 4b |
| Sep 30 2019 | DKK 17m | DKK 10m | DKK 4b |
| Jun 30 2019 | n/a | n/a | DKK 4b |
| Mar 31 2019 | n/a | n/a | DKK 4b |
| Dec 31 2018 | n/a | n/a | DKK 4b |
| Sep 30 2018 | DKK 11m | DKK 6m | DKK 4b |
Compensation vs Market: Kristian's total compensation ($USD3.10M) is about average for companies of similar size in the Danish market ($USD3.68M).
Compensation vs Earnings: Kristian's compensation has been consistent with company performance over the past year.
CEO
Kristian Villumsen (54 yo)
5.9yrs
Tenure
DKK 22,000,000
Compensation
Mr. Kristian Villumsen has been Independent Director of Demant A/S since March 5, 2021. He has been the President and Chief Executive Officer of Coloplast A/S since December 4, 2018. Mr. Villumsen was an E...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & CEO | 5.9yrs | DKK 22.00m | 0.045% DKK 90.1m | |
| Executive VP & CFO | 10.3yrs | DKK 11.30m | 0.0012% DKK 2.4m | |
| Executive Vice President of Global Operations | 10.3yrs | DKK 9.90m | 0.011% DKK 22.7m | |
| Executive Vice President of Chronic Care | no data | DKK 9.50m | no data | |
| Executive Vice President of Growth | 5.8yrs | DKK 11.50m | 0.014% DKK 27.1m | |
| Senior Controller & Employees Representative Director | no data | DKK 450.00k | 0.000020% DKK 40.1k | |
| Vice President of Investor Relations | no data | no data | no data | |
| Vice President of Corporate Communications | no data | no data | no data | |
| Executive Vice President of People & Culture | 2.8yrs | no data | no data | |
| Senior Vice President of Sales Europe | 12.6yrs | no data | no data | |
| Executive Vice President of Voice & Respiratory Care | no data | no data | no data | |
| Senior Vice President of Wound & Skin Care | 4.2yrs | no data | no data |
5.9yrs
Average Tenure
55yo
Average Age
Experienced Management: COLO B's management team is seasoned and experienced (5.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Senior Controller & Employees Representative Director | 18.8yrs | DKK 450.00k | 0.000020% DKK 40.1k | |
| Independent Director | 6.9yrs | DKK 690.00k | 0.0027% DKK 5.3m | |
| Independent Chairman of the Board | 5.9yrs | DKK 1.84m | 0.0054% DKK 10.8m | |
| Deputy Chairman | 56.8yrs | DKK 938.00k | 1.93% DKK 3.9b | |
| Independent Director | 3.9yrs | DKK 880.00k | 0.00022% DKK 440.8k | |
| Independent Director | 8.9yrs | DKK 600.00k | no data | |
| Employees Representative Director | 6.8yrs | DKK 450.00k | no data | |
| Employees Representative Director | 6.8yrs | DKK 450.00k | 0.00072% DKK 1.4m | |
| Independent Director | 2.9yrs | DKK 600.00k | no data |
6.8yrs
Average Tenure
59yo
Average Age
Experienced Board: COLO B's board of directors are considered experienced (6.8 years average tenure).